Study shows Novo's new diabetes drug effective and safe for children
September 16, 2014 at 05:59 AM EDT
COPENHAGEN, Sept 16 (Reuters) - Novo Nordisk's new long-acting insulin Tresiba has been shown to be effective and safe for long-term use in children and young adults with type 1 diabetes, according to new data from a late-stage trial presented on Tuesday.
